Special Issues
Table of Content

Metabolism of Cancer Cells and Immune Cells: A Balancing Action for Cancer Immunotherapy

Submission Deadline: 30 June 2024 (closed) View: 142

Guest Editors

Huashan Shi, Cancer Center, West China Hospital, Chengdu, China. E-mail: shihuashan@scu.edu.cn

Yingfeng Wan, Department of Neurosurgery, Medical School,University of Michigan, Ann Arbor, USA. E-mail: yingfenw@med.umich.edu

Xuyu Gu, Department of Oncology, Zhongda Hospital, School of medicine, Southeast University, Nanjing, China. E-mail: guxuyu@126.com

Jian Zhang, School of Computer and Information Technology, Xinyang Normal University, Xinyang, Henan, China. E-mail: jianzhang@xynu.edu.cn

Haiting Chai, Nuffield Department of Medicine, University of Oxford, UK. E-mail: haiting.chai@ndm.ox.ac.uk

Summary

Cells require energy to maintain their survival, and various metabolites are also bioactive. It has now been recognized that metabolism regulates the phenotype and biological function of cells. In the tumor microenvironment (TME), tumor cells and immune cells reprogram their metabolic patterns to adapt to the hypoxic, acidic, and low-nutrition microenvironment. The crosstalk between tumor cells and immune cells in the TME manipulates the development of tumors. Although the recent advancement of immunotherapy was encouraging, and countless patients have achieved significant benefits, some patients still do not respond to immunotherapy, due to the complexity and diversity of the TME. Exploring the underlying mechanisms of TME-driven tumorigenesis and progression are essential for developing potential precise approaches for cancer treatment. The molecular pathways that control immune cell metabolism and function are intimately linked. Understanding such metabolic reprogramming of immune cells in the tumor microenvironment could offer new directions in manipulation of peripheral immune responses. Recent findings in immune cell metabolism hold the promising possibilities by metabolic manipulation of immune cells towards clinical therapeutics for treating cancer.

 

This topic will include updated findings and views in the metabolism of cancer cells and immune cells in the tumor microenvironment. We welcome submissions of Original Research, Reviews, Mini-Reviews, Opinions and Perspective Articles covering, but not limited to, the following topics:

(1) The crosstalk between tumor cells and immune cells

(2) Mechanisms of changes in metabolism of functional immune cells (including suppressive and killer immune cells) in cancers

(3) The impact of metabolism of cancer cells and immune cells on immunotherapy


Keywords

metabolism, glycolysis, oxidative phosphrylation, tumor microenvironment, immune cells, glutaminolysis, T cells, macrophages, immunotherapy

Published Papers


  • Open Access

    REVIEW

    The role of cholesterol metabolism in lung cancer

    WEIGANG XIU, XINGYU LIU, KAIXIN HU, QIN ZHANG, HUASHAN SHI
    Oncology Research, Vol.32, No.10, pp. 1613-1621, 2024, DOI:10.32604/or.2024.047933
    (This article belongs to the Special Issue: Metabolism of Cancer Cells and Immune Cells: A Balancing Action for Cancer Immunotherapy)
    Abstract Elevated serum cholesterol metabolism is associated with a reduced risk of lung cancer. Disrupted cholesterol metabolism is evident in both lung cancer patients and tumor cells. Inhibiting tumor cell cholesterol uptake or biosynthesis pathways, through the modulation of receptors and enzymes such as liver X receptor and sterol-regulatory element binding protein 2, effectively restrains lung tumor growth. Similarly, promoting cholesterol excretion yields comparable effects. Cholesterol metabolites, including oxysterols and isoprenoids, play a crucial role in regulating cholesterol metabolism within tumor cells, consequently impacting cancer progression. In lung cancer patients, both the cholesterol levels in the… More >

Share Link